Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …

Demyelinating diseases are a group of autoimmune inflammatory disorders affecting the
central nervous system in adults and children; however, the diagnosis, evaluation, and …

Multiple sclerosis (MS) is a demyelinating and neurodegenerative disorder of the central
nervous system, for which disease modifying therapies (DMTs) are the mainstay treatment …

Multiple sclerosis (MS) is a chronic disease in which the immune system attacks the central
nervous system, causing inflammation and neurodegeneration. People living with MS may …

Multiple sclerosis (MS) is commonly diagnosed in young adults during their reproductive
years. Consequently, concerns about family planning and MS management related to …

The coronavirus disease 2019 (COVID-19) pandemic has catalyzed the rapid adoption of
telemedicine which encompasses synchronous and asynchronous interactions between …

BACKGROUND: Glatiramer acetate is an immunomodulatory drug that is widely prescribed
for the treatment of multiple sclerosis. It is frequently associated with local injection site …

Background: Severe residual visual loss (SRVL) is frequent in neuromyelitis optica
spectrum disorders (NMOSD). Identifying higher-risk patients at onset is important to prevent …

Background: Shared medical appointments (SMAs) are group medical visits combining medical
care and patient education. We examined the impact of a wellness-focused pilot SMA in …

Multiple sclerosis (MS) patients need monitoring and treatment by a neurologist with experience
in MS. In addition to this, we now know that age-appropriate health screens, vascular …